Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Riccardo Ferro
Observed names:
Ferro, Riccardo,
R. Ferro
Institutions:
Institute of Cancer Research,
King's College London,
Breast Cancer Now
Observed institutions:
University of London,
Institute of Cancer Research,
Queen Mary University of London,
King's College London,
Breast Cancer Now,
Institute of Cancer Research,
Kings Health Partners,
Blizard Institute
show all 8
ORCID:
0000-0001-6532-4856
Observed ORCID:
0000-0001-6532-4856
OpenAlex ID:
A5073396282
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine
2018
·
R. Ferro
, A. Adamska
, et al.
·
Oncogene
·
123
CD31 signals confer immune privilege to the vascular endothelium
2015
·
Kenneth Cheung
, Liang Ma
, et al.
·
Proceedings of the National Academy of Sciences
·
97
Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancer
2018
·
Nirmesh Patel
, Daniel Weekes
, et al.
·
Nature Communications
·
71
PDF
Role of the lysophosphatidylinositol/GPR55 axis in cancer
2015
·
Marco Falasca
, Riccardo Ferro
·
Advances in Biological Regulation
·
58
Emerging role of the KRAS-PDK1 axis in pancreatic cancer
2014
·
Riccardo Ferro
, Marco Falasca
·
World Journal of Gastroenterology
·
46
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression
2016
·
Anissa Chikh
, Riccardo Ferro
, et al.
·
Oncotarget
·
42
PDF
Lysophosphatidylinositol: a novel link between ABC transporters and G-protein-coupled receptors
2014
·
Emily L. Ruban
, Riccardo Ferro
, et al.
·
Biochemical Society Transactions
·
38
A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion
2016
·
Claudio Raimondi
, Veronique Calleja
, et al.
·
Scientific Reports
·
36
PDF
ABCC3 is a novel target for the treatment of pancreatic cancer
2019
·
Aleksandra Adamska
, Riccardo Ferro
, et al.
·
Advances in Biological Regulation
·
35
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer
2019
·
Aikaterini Emmanouilidi
, Chanse A. Fyffe
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
24
PDF
CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models
2022
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
·
Cancers
·
23
PDF
Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance
2022
·
Dalia Tarantino
, Callum Walker
, et al.
·
Oncogene
·
17
PDF
Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors
2026
·
Callum Walker
, Gabriel Kollarovic
, et al.
·
Nature Communications
·
3
PDF
Tracing the evolutionary trajectory of CDK4/6 inhibitor resistance in oestrogen receptor positive breast cancer
2025
·
Rachael Natrajan
, Ioanna Mavrommati
, et al.
·
Research Square
·
1
PDF
The anion channel GPR89 is a novel oncogene associated with tumour specific dependency in breast cancer
2022
·
R. Ferro
, A. Carroll
, et al.
·
European Journal of Cancer
·
1
PDF
Abstract 443: The anion channel GPHR/GPR89 regulates protein-folding homeostasis by regulating the IRE1α pathway in breast cancer
2018
·
Riccardo Ferro
, Pierfrancesco Marra
, et al.
·
Cancer Research
·
1
The anion channel GPR89 is a tumor-specific dependency in breast cancer
2026
·
Riccardo Ferro
, Alexandra Carroll
, et al.
·
Nature Communications
PDF
298 (PB286): Targeting GPR89 as a novel therapeutic strategy for breast cancer
2024
·
R. Ferro
, A. Carroll
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
20
Citation count:
616
H-index:
12
I10-index:
12
Year
Topic
Type